Meyer, Pierre
Centre National de la Recherche Scientifique · Inserm · Université de Montpellier · Physiologie et Médecine Expérimentale du Coeur et des Muscles · Centre Hospitalier Universitaire de Montpellier
4 papers on CoChatORCID 0000-0001-5710-7376
Most cited papers
- Verified
Reverse-Transcriptase Inhibitors in the Aicardi–Goutières Syndrome
Rice, G. I., Meyzer, C., Bouazza, N., Hully, M., Boddaert, N., Semeraro, M., Zeef, L. A. H., Rozenberg, F., Bondet, V., Duffy, D., et al. (2018) · New England Journal of Medicine
HIV/AIDS drug development and treatmentImmunodeficiency and Autoimmune Disorders
Cited by 153
- Verified
Gain-of-function and loss-of-function GABRB3 variants lead to distinct clinical phenotypes in patients with developmental and epileptic encephalopathies
Absalom, N. L., Liao, V. W. Y., Johannesen, K. M. H., Gardella, E., Jacobs, J., Lesca, G., Gokce-Samar, Z., Arzimanoglou, A., Zeidler, S., Striano, P., et al. (2022) · Nature Communications
Epilepsy research and treatmentGenetics and Neurodevelopmental Disorders
Cited by 89
- Verified
New insights into the clinical and molecular spectrum of the novel CYFIP2-related neurodevelopmental disorder and impairment of the WRC-mediated actin dynamics
Begemann, A., Sticht, H., Begtrup, A., Vitobello, A., Faivre, L., Banka, S., Alhaddad, B., Asadollahi, R., Becker, J., Bierhals, T., et al. (2021) · Genetics in Medicine
Genetics and Neurodevelopmental DisordersGenomics and Rare Diseases
Cited by 61
- Verified
Distinct neurodevelopmental and epileptic phenotypes associated with gain- and loss-of-function GABRB2 variants
Mohammadi, N. A., Ahring, P. K., Yu Liao, V. W., Chua, H. C., Ortiz de la Rosa, S., Johannesen, K. M., Michaeli-Yossef, Y., Vincent-Devulder, A., Meridda, C., Bruel, A.-L., et al. (2024) · eBioMedicine
Epilepsy research and treatmentGenetics and Neurodevelopmental Disorders
Cited by 27
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free